Q56.4

Clinical Causes: Hormonal imbalances during fetal development, such as excess or deficiency of sex hormones Genetic disorders affecting sex chromosome composition, such as XXY or XO syndromes Congenital adrenal hyperplasia, which involves enzyme deficiencies affecting hormone production Androgen insensitivity syndrome, where the body's cells cannot respond to male hormones Structural anomalies in gonads or reproductive organs during fetal development Chromosomal abnormalities that alter typical sex-determining processes

Key Symptoms: Presence of ambiguous or atypical genitalia at birth, such as enlarged clitoris, micropenis, or hypospadias Discrepancy between genetic sex and physical characteristics Possible hormonal imbalances detected during neonatal screening Variations in internal reproductive organs, which may require imaging studies for clarification Potential psychological or social challenges related to gender identity

Diagnosis Path: Chromosomal analysis (karyotyping) to determine genetic sex Hormonal assays to evaluate levels of sex hormones such as testosterone, estrogen, and cortisol Ultrasound or MRI scans to visualize internal reproductive organs Genetic testing to identify specific disorders or mutations Assessment by specialists in endocrinology, genetics, and pediatrics for comprehensive evaluation

Treatment Protocols: Hormone therapy to induce or suppress secondary sexual characteristics as appropriate Surgical procedures to modify genitalia for functional or cosmetic reasons, tailored to individual needs Psychological counseling for the individual and family to address emotional and social concerns Long-term follow-up with specialists to monitor growth, development, and reproductive health Support groups and advocacy organizations to assist individuals and families in navigating social and emotional aspects